Drugs and Devices

FDA releases draft guideline related to nanotechnology

The Food and Drug Administration (FDA) has released “Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology,” a draft guidance document available for comment. The goal is “to provide regulated industries with greater certainty about the use of nanotechnology. Read more.


Related Articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

 

Shares